Correlation between activated partial thromboplastin time and diluted Russell’s viper venom time in the presence of lupus anticoagulant

Lupus anticoagulant (LA) is a heterogeneous group of antibodies that interfere with phospholipid-dependent coagulation tests, which result in abnormally prolonged clotting times in vitro. The prevalence of LA in a healthy individual is 1-5%1,2.

Guardado en:

Detalles Bibliográficos
Autores principales:	Luz Tarín-Arzaga, Carlos de la Cruz-de la Cruz, Martha A. Reyes-López, Omar Cantu-Martinez, Karina Vázquez-Hernández, Odra Martínez-González, Luis A. González-Torres, Luis J. Marfil-Rivera, David Gómez-Almaguer
Formato:	article
Lenguaje:	EN ES
Publicado:	Permanyer 2021
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/9d4a03b97ebb4a9da4202e6a3f9048a9
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:9d4a03b97ebb4a9da4202e6a3f9048a9
record_format	dspace
spelling	oai:doaj.org-article:9d4a03b97ebb4a9da4202e6a3f9048a92021-11-04T01:15:10ZCorrelation between activated partial thromboplastin time and diluted Russell’s viper venom time in the presence of lupus anticoagulant10.24875/RMU.200000741665-57962530-0709https://doaj.org/article/9d4a03b97ebb4a9da4202e6a3f9048a92021-01-01T00:00:00Zhttps://www.medicinauniversitaria.org/frame_esp.php?id=123https://doaj.org/toc/1665-5796https://doaj.org/toc/2530-0709 Lupus anticoagulant (LA) is a heterogeneous group of antibodies that interfere with phospholipid-dependent coagulation tests, which result in abnormally prolonged clotting times in vitro. The prevalence of LA in a healthy individual is 1-5%1,2. Luz Tarín-ArzagaCarlos de la Cruz-de la CruzMartha A. Reyes-LópezOmar Cantu-MartinezKarina Vázquez-HernándezOdra Martínez-GonzálezLuis A. González-TorresLuis J. Marfil-RiveraDavid Gómez-AlmaguerPermanyerarticleMedicine (General)R5-920ENESMedicina Universitaria, Vol 23, Iss 1 (2021)
institution	DOAJ
collection	DOAJ
language	EN ES
topic	Medicine (General) R5-920
spellingShingle	Medicine (General) R5-920 Luz Tarín-Arzaga Carlos de la Cruz-de la Cruz Martha A. Reyes-López Omar Cantu-Martinez Karina Vázquez-Hernández Odra Martínez-González Luis A. González-Torres Luis J. Marfil-Rivera David Gómez-Almaguer Correlation between activated partial thromboplastin time and diluted Russell’s viper venom time in the presence of lupus anticoagulant
description	Lupus anticoagulant (LA) is a heterogeneous group of antibodies that interfere with phospholipid-dependent coagulation tests, which result in abnormally prolonged clotting times in vitro. The prevalence of LA in a healthy individual is 1-5%1,2.
format	article
author	Luz Tarín-Arzaga Carlos de la Cruz-de la Cruz Martha A. Reyes-López Omar Cantu-Martinez Karina Vázquez-Hernández Odra Martínez-González Luis A. González-Torres Luis J. Marfil-Rivera David Gómez-Almaguer
author_facet	Luz Tarín-Arzaga Carlos de la Cruz-de la Cruz Martha A. Reyes-López Omar Cantu-Martinez Karina Vázquez-Hernández Odra Martínez-González Luis A. González-Torres Luis J. Marfil-Rivera David Gómez-Almaguer
author_sort	Luz Tarín-Arzaga
title	Correlation between activated partial thromboplastin time and diluted Russell’s viper venom time in the presence of lupus anticoagulant
title_short	Correlation between activated partial thromboplastin time and diluted Russell’s viper venom time in the presence of lupus anticoagulant
title_full	Correlation between activated partial thromboplastin time and diluted Russell’s viper venom time in the presence of lupus anticoagulant
title_fullStr	Correlation between activated partial thromboplastin time and diluted Russell’s viper venom time in the presence of lupus anticoagulant
title_full_unstemmed	Correlation between activated partial thromboplastin time and diluted Russell’s viper venom time in the presence of lupus anticoagulant
title_sort	correlation between activated partial thromboplastin time and diluted russell’s viper venom time in the presence of lupus anticoagulant
publisher	Permanyer
publishDate	2021
url	https://doaj.org/article/9d4a03b97ebb4a9da4202e6a3f9048a9
work_keys_str_mv	AT luztarinarzaga correlationbetweenactivatedpartialthromboplastintimeanddilutedrussellsvipervenomtimeinthepresenceoflupusanticoagulant AT carlosdelacruzdelacruz correlationbetweenactivatedpartialthromboplastintimeanddilutedrussellsvipervenomtimeinthepresenceoflupusanticoagulant AT marthaareyeslopez correlationbetweenactivatedpartialthromboplastintimeanddilutedrussellsvipervenomtimeinthepresenceoflupusanticoagulant AT omarcantumartinez correlationbetweenactivatedpartialthromboplastintimeanddilutedrussellsvipervenomtimeinthepresenceoflupusanticoagulant AT karinavazquezhernandez correlationbetweenactivatedpartialthromboplastintimeanddilutedrussellsvipervenomtimeinthepresenceoflupusanticoagulant AT odramartinezgonzalez correlationbetweenactivatedpartialthromboplastintimeanddilutedrussellsvipervenomtimeinthepresenceoflupusanticoagulant AT luisagonzaleztorres correlationbetweenactivatedpartialthromboplastintimeanddilutedrussellsvipervenomtimeinthepresenceoflupusanticoagulant AT luisjmarfilrivera correlationbetweenactivatedpartialthromboplastintimeanddilutedrussellsvipervenomtimeinthepresenceoflupusanticoagulant AT davidgomezalmaguer correlationbetweenactivatedpartialthromboplastintimeanddilutedrussellsvipervenomtimeinthepresenceoflupusanticoagulant
_version_	1718445348743020544

Correlation between activated partial thromboplastin time and diluted Russell’s viper venom time in the presence of lupus anticoagulant

Ejemplares similares